Orum Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 26, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Debt / Equity Ratio	0.17	0.23	0.20	0.24
Debt / EBITDA Ratio	-	-	0.27	-
Debt / FCF Ratio	-	-	0.28	-
Net Debt / Equity Ratio	-0.82	-0.74	-0.78	-0.89
Net Debt / EBITDA Ratio	3.09	16.55	-1.03	0.22
Net Debt / FCF Ratio	3.36	7.21	-1.08	0.23
Asset Turnover	0	0.13	1.48	-
Quick Ratio	9.92	3.81	13.92	1.36
Current Ratio	10.32	3.85	13.95	1.42
Return on Equity (ROE)	-26.72%	-4.57%	97.53%	-
Return on Assets (ROA)	-15.12%	-3.30%	65.28%	-
Return on Capital Employed (ROCE)	-24.70%	-6.80%	62.60%	-353.10%
Buyback Yield / Dilution	79.34%	-20.20%	-227.30%	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.